← Back to Search

NGS

Intervention Group (NGS + Antibiotic Recommendation) for Bacterial Infection (ACCESS Trial)

N/A
Waitlist Available
Led By Michael Liss, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one to two weeks after surgery (approximately 100 days from baseline)
Awards & highlights

ACCESS Trial Summary

This trial will test whether using NGS to guide antibiotic prescribing before common urinary tract procedures can improve patient outcomes.

Eligible Conditions
  • Bacterial Infection
  • Kidney Stones

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one to two weeks after surgery (approximately 100 days from baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and one to two weeks after surgery (approximately 100 days from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Infection Post Surgery
Secondary outcome measures
Number of Participants for Whom Additional Antibiotics Were Selected

ACCESS Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention Group (NGS + Antibiotic Recommendation)Experimental Treatment1 Intervention
Next Generation Sequencing results along with Infectious Disease Pharmacist will be shared with clinical provider to determine appropriate standard of care antibiotic treatment at time of standard of care urology stone procedure. Standard of care antibiotic selection will be up to the discretion of the clinical provider.
Group II: Control GroupExperimental Treatment1 Intervention
NGS results will not be shared with the clinical provider at time of standard of care urology stone procedure. Standard of care antibiotic selection will be up to the discretion of the clinical provider.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard of Care treatment
2019
N/A
~240

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,174 Total Patients Enrolled
MicroGen DXUNKNOWN
Michael Liss, MDPrincipal InvestigatorUniversity of Texas Health at San Antonio
2 Previous Clinical Trials
2,538 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any spots vacant for this clinical experiment?

"The details found on clinicaltrials.gov verify that this research trial is currently enrolling patients. The original posting date was December 18th 2019, with the most recent update being June 18th 2021."

Answered by AI

How many participants are currently enrolled in this experiment?

"Affirmative. Online records on clinicaltrials.gov confirm that this medical trial, initially posted in December 2019, is currently seeking participants. It demands a total of 220 volunteers from 3 separate sites."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
2019. "Antibiotic Selection Using Next Generation Sequencing vs Urine Culture". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04404855.
~45 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top